translational, cancer research, xenograft, prostate cancer
A postdoctoral training position in translational cancer biology is currently available in the Laboratory of Genitourinary Cancer Pathogenesis (LGCP) of the National Cancer Institute (NCI). The position is located in the laboratory of David VanderWeele M.D., Ph.D., whose research group uses in vitro and in vivo functional studies and pathology specimens and next-generation sequencing data to identify and target drivers of prostate cancer progression.
The laboratory is interested in characterizing clinically significant, potentially lethal prostate cancer. We are specifically interested in molecular alterations that drive progression of subclones to dominance development of metastatic disease and characterizing therapeutic vulnerabilities. Current work is aimed at using xenograft and organoid models to further characterize the role of putative drivers of progression, and to develop ways to target these alterations.
Candidates should have or be close to obtaining a Ph.D. or equivalent degree in cell biology, molecular biology, or a related field, with no more than 3 years postdoctoral experience. Experience in organoid culture, bioinformatics, mouse work, and molecular techniques is desirable. Applicants must possess good communication skills and be fluent in both spoken and written English. The ability to quickly become expert in the use of new techniques, critical thinking, problem-solving abilities, and the ability to work semi-independently are required.
If interested, contact:
David VanderWeele, M.D., Ph.D.
Assistant Clinical Investigator
Laboratory for Genitourinary Cancer Pathogenesis
Center for Cancer Research
National Cancer Institute, NIH
37 Convent Drive, Rm 1066A
Bethesda, MD. 20892
HHS, NIH, and NCI are Equal Opportunity Employers